Analyst Ratings For Intec Pharma (NASDAQ:NTEC)
Today, Oppenheimer reiterated its Buy rating on Intec Pharma (NASDAQ:NTEC).
Some recent analyst ratings include
- 3/21/2018-Oppenheimer Reiterated Rating of Buy.
- 2/28/2018-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
- 9/21/2017-CIBC Reiterated Rating of Outperform .
Recent Trading Activity for Intec Pharma (NASDAQ:NTEC)
Shares of Intec Pharma closed the previous trading session at 6.30 +0.00 0.00% with 6.25 shares trading hands.